New Zealand markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
39.16+3.59 (+10.09%)
As of 03:46PM EDT. Market open.
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-44,603
-44,603
-42,347
-45,640
-111,269
Depreciation & amortisation
640.601
640.601
762.995
1,639
1,694
Stock-based compensation
3,470
3,470
5,720
9,480
12,458
Change in working capital
4,094
4,094
-3,299
-15,696
-3,205
Accounts receivable
-
-
-
-
0
Accounts payable
1,028
1,028
-256.835
-5,956
-3,469
Other working capital
-36,100
-36,100
-37,558
-48,238
-100,170
Other non-cash items
824.381
824.381
742.478
950.613
291.392
Net cash provided by operating activities
-36,100
-36,100
-37,544
-48,184
-99,686
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-13.449
-54.172
-484.491
Purchases of investments
-33,885
-33,885
-86,342
-87,267
0
Sales/maturities of investments
69,527
69,527
116,421
13,880
0
Net cash used for investing activities
35,642
35,642
30,074
-73,417
-484.491
Cash flows from financing activities
Debt repayment
-3,247
-3,247
-2,368
-926.595
-951.876
Common stock issued
244.302
244.302
0
62,586
142,201
Other financing activities
-190.902
-190.902
-
-1,820
-6,039
Net cash used provided by (used for) financing activities
-2,821
-2,821
-533.615
60,823
154,875
Net change in cash
-3,279
-3,279
-8,004
-60,777
54,705
Cash at beginning of period
17,673
17,673
25,677
86,453
31,749
Cash at end of period
14,394
14,394
17,673
25,677
86,453
Free cash flow
Operating cash flow
-36,100
-36,100
-37,544
-48,184
-99,686
Capital expenditure
-
-
-13.449
-54.172
-484.491
Free cash flow
-36,100
-36,100
-37,558
-48,238
-100,170